Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement.
Bernardo StefaniniMatteo TonniniIlaria SerioMatteo RenzulliFrancesco TovoliPublished in: Expert review of anticancer therapy (2022)
Surveillance is recognized as a tool to favor early diagnosis of HCC, access to curative treatment, and increase survival, even if the supporting evidence is mainly based on observational studies. As new randomized clinical trials are difficult to propose, future challenges will include optimizing implementation in the primary care setting and a more personalized approach, balancing the opportunities and risks of overdiagnosis of novel techniques and biomarkers.